| Line Item | 2026-03-29 | Q/Q | Y/Y |
|---|---|---|---|
| Revenue | $158.8M | — | -2.0% |
| Cost of Revenue | $94.5M | — | -10.6% |
| Gross Profit | $64.3M | — | +14.2% |
| R&D Expense | $21.7M | — | +18.3% |
| SG&A Expense | $19.2M | — | +6.2% |
| Operating Income | -$13.6M | — | -6.2% |
| Pre-tax Income | -$12.0M | — | -159.5% |
| Income Tax | $1.0M | — | -26.8% |
| Net Income | -$13.0M | — | -116.1% |
| EPS (Basic) | -$0.47 | — | -123.8% |
| EPS (Diluted) | -$0.47 | — | -123.8% |
| Line Item | 2026-03-29 | Q/Q | Y/Y |
|---|---|---|---|
| Cash & Equivalents | $183.5M | -12.6% | -32.0% |
| Short-term Investments | $113.0M | -0.1% | -7.4% |
| Accounts Receivable | $142.2M | +0.1% | -0.4% |
| Inventory | $169.3M | -4.1% | +7.2% |
| Current Assets | $642.8M | -4.5% | -11.2% |
| Total Assets | $801.9M |
| Line Item | 2026-03-29 | Q/Q | Y/Y |
|---|---|---|---|
| Operating Cash Flow | $1.6M | — | +118.8% |
| Capital Expenditures | $3.8M | — | +173.8% |
| Investing Cash Flow | -$4.0M | — | -215.4% |
| Financing Cash Flow | -$24.1M | — | -263.8% |
| Free Cash Flow | -$2.2M | — | +78.5% |
| -1.5% |
| Current Liabilities | $248.7M | -0.6% | +2.8% |
| Total Liabilities | $330.8M | -2.3% | +18.2% |
| Stockholders' Equity | $471.2M | -5.4% | -11.8% |